A study of automatic control with remifentanil and rocuronium for individuals in general anesthesia

A study of automatic control with remifentanil and rocuronium for individuals in general anesthesia - automatic control with remifentanil and rocuronium

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033379

Enrollment

200

Registered

2023-03-31

Start date

2018-05-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients scheduled for elective surgery requiring general anesthesia

Interventions

Automatic control group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients scheduled for elective surgery requiring general anesthesia

Exclusion criteria

Exclusion criteria: Patients with poor general condition

Design outcomes

Primary

Measure	Time frame
the percentage of time PTC>2,T1<10%,time to T1>25% and T1>75%,time to T1>90%,T1>100% or TOF ratio 0.95 from administration after sugammadex administration, esmic valiability	—

Countries

Japan

Contacts

Public ContactYuka Matsuki

Faculty of Medicine Sciences, University of Fukui Department of Anesthesiology & Reanimatology

ymatsuki@u-fukui.ac.jp0776618391

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026